Post-market surveillance is critical for ongoing quality assurance. This involves monitoring the vaccine's performance in the real world to identify any rare or long-term adverse effects. Regulatory bodies require manufacturers to collect and analyze post-approval data, ensuring any issues are promptly addressed.
